Huron Consulting Group Inc. (HURN) Stock Price & How to Invest

Huron Consulting Group was formed in 2002 by former Arthur Andersen partners and has built itself into a global professional services firm organized around three industry segments. Healthcare produced ~50% of revenues before reimbursable expenses in the first half of 2026, Education ~29%, and Commercial ~21%. The work runs through two capabilities: consulting and managed services covers performance improvement, cost reduction, clinical operations, revenue cycle and research administration, while the digital practice implements and then operates enterprise platforms from Workday, Oracle and Salesforce for the same client base. As of June 30, 2026 Huron employed ~5,335 revenue-generating professionals outside managed services, plus ~3,913 managed services staff, a headcount that more than doubled year over year after the RelateCare acquisition added roughly ~1,100 people in patient access. Buying capability is a standing part of the model, with Eclipse Insights, Treliant and WP&C folded in during 2025.

The June 2026 quarter was a record on the company's own numbers: revenues before reimbursable expenses of ~$465.6M, up ~15.7% year over year and ~10.8% excluding acquisitions, adjusted EBITDA of ~$72.6M, and management raising full-year RBR guidance to a range of ~$1.85B to ~$1.89B. The share price has told a different story. Shares reached ~$187 at the 52-week high and ~$85 at the low, and the company itself repurchased stock at an average of ~$97 during June, before the late-July report pushed the price back toward ~$152. What moved was the multiple rather than the results, as investors argued over whether generative AI compresses the billable hours consultancies sell. Leverage moved too. Net debt stood at ~$833M and the consolidated leverage ratio at ~2.8x on June 30, against ~1.9x at the end of 2025, the product of ~$208.6M of buybacks in six months alongside deal spending.

The central risk is the one the market has already repriced twice this year: if generative AI compresses the hours clients will pay for, a business built on utilization and staffing leverage degrades fast, and Huron's consulting utilization near ~81% sits closer to the top of its historical range than the bottom. Leverage has climbed sharply in six months, to a consolidated leverage ratio of ~2.8x against a ~3.75x covenant limit, which narrows the room for both further buybacks and further acquisitions. The balance sheet carries ~$805M of net goodwill after ~$456M of accumulated impairments from earlier deals, so this is a company that has written down acquisitions before. Education revenue is exposed to university budgets and federal research funding, neither of which is settled. In the Form 10-Q for the quarter ended June 30, 2026, Huron stated it is not party to any litigation management expects to have a material adverse effect, and no securities class action is disclosed.

4 analysts publish price targets on HURN, averaging $190.75 against a $151.87 price as of August 2026, or +25.6%. The published targets run from $160.00 to $215.00, a narrow spread, and the ratings split 5 buy, 0 hold, 0 sell. Over the last six months there have been 0 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full HURN forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Huron Consulting Group Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Healthcare demand and the shift toward managed services. Healthcare is the largest segment, at ~$232.3M of RBR in Q2 2026, up ~17% year over year, on segment operating income of ~$69.9M. The most optimistic published target, $215.00, assumes this works close to its best case.

The case against. The central risk is the one the market has already repriced twice this year: if generative AI compresses the hours clients will pay for, a business built on utilization and staffing leverage degrades fast, and Huron's consulting utilization near ~81% sits closer to the top of its historical range than the bottom. The most pessimistic target, $160.00, is roughly what HURN is worth if this bites instead.

Read the full bull and bear case on HURN, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Huron Consulting Group Inc.'s investor relations page or your broker.

• Revenue (TTM, before reimbursable expenses): ~$1.77B
• 2026 RBR guidance: ~$1.85B to ~$1.89B
• Adjusted diluted EPS guidance (2026): ~$9.00 to ~$9.40
• Market cap: ~$2.4B
• Forward P/E on 2026 adjusted EPS: ~16x
• Net debt: ~$833M (~2.8x leverage)

At roughly ~$152 a share against ~15.9M shares outstanding, Huron carries a market capitalization near ~$2.4B and an enterprise value around ~$3.2B once net debt is counted. That works out to about ~16x the midpoint of management's 2026 adjusted EPS guidance and roughly ~12x guided adjusted EBITDA, below where the larger listed consultancies have typically traded. Trailing GAAP earnings look considerably weaker than the adjusted figures because of intangible amortization, transaction costs and investment write-downs, and the gap between the two is wide enough to be worth re-checking each quarter.

Other names that sit close to HURN: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get HURN exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so HURN sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where HURN fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Huron is a profitable, growing, moderately levered services business whose share price now moves more on what investors believe AI does to consulting than on what the company actually reports.

Whether HURN is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is HURN a buy or a sell?, and where the stock could go from here in the HURN stock forecast.

For income investors, whether HURN pays a dividend and how the payout looks is covered in does HURN pay a dividend? And to weigh HURN against a peer, read the full side-by-side comparisons: HURN vs FCN and HURN vs EXPO.